Navigation Links
National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production

LOUISVILLE, Ky., Nov. 20 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) today announced a new initiative in the war on methamphetamine. The National Precursor Log Exchange (NPLEx) is a multi-state electronic tracking program that enforces purchase limitations on over-the-counter (OTC) medicines containing pseudoephedrine in real-time at the point of sale. The technology for NPLEx is based on a system that was developed and tested in Kentucky in 2005 and expanded statewide in late 2007. Today Kentucky, Illinois, and Louisiana are executing agreements with NADDI to become the first three states to adopt NPLEx as their electronic tracking program.


NPLEx provides law enforcement agencies across the country with free access to the multi-state electronic log of cold and allergy medicine purchases. The system helps retailers and consumers stay in compliance with state and federal laws that place restrictions on these medicines. These OTC cold and allergy medicines contain pseudoephedrine, a key ingredient diverted to illegally manufacture methamphetamine. The program has been modeled after the successful efforts in Kentucky to combat domestic meth production. The cost of deploying and supporting the NPLEx system has been covered by a private-public partnership that NADDI negotiated with the leading manufacturers of these medicines. Consequently, states that are offered NPLEx can deploy and support the system without the use of government funds.

"Rarely are states able to easily work together to tackle a problem that crosses state lines," said Charlie Cichon, director of NADDI. "We believe many states will adopt NPLEx over the next several years, making it more difficult for these common medicines to be diverted into the illegal manufacture of methamphetamine."

The NPLEx program is now being offered at no cost to states that have passed legislation to adopt real-time tracking of the medicines. This initiative has proven to be successful at enforcing the legal purchase limits enacted by state and federal legislators. The program has also given law enforcement a powerful new intelligence tool to locate more people involved in these crimes, and to find a higher percentage of meth labs.

"Like most states, we have felt the pain associated with this terrible drug," said Kentucky Gov. Steve Beshear. "We are proud that Kentucky has been able to lead in the development of this technology platform. By reaching across our borders, we are preventing people from diverting illegal amounts of these cold and allergy medicines for the manufacture of methamphetamine."

The technology is used today to deny more than 5,000 monthly purchases of cold and allergy medicines in Kentucky that would otherwise exceed the legal limits. Law enforcement is able to immediately access electronic records, allowing them to better track meth lab suppliers.

"We are happy to be one of the first states to join the NPLEx coalition. In these difficult fiscal times, it is unusual that we find a way to implement solutions without the use of taxpayer funds," said Illinois State Police Lt. Colonel Rob Haley. "We are excited and ready to put this program in place, making it more difficult for criminals to divert these products for illegal use."

Louisiana's legislature passed a bill requiring electronic tracking, and officials there are seeking to establish NPLEx this year. "The only way for us to effectively fight the production of illegal meth is to work together," said Louisiana State Police Captain Charlie Dupuy.

In July, the National Sheriffs' Association and its Drug Enforcement Committee passed a resolution endorsing an industry-funded solution for electronic tracking of pseudoephedrine purchases in real time.

"It is uncommon to see action of this magnitude this quickly, particularly when dealing with multiple states and some reasonably complicated technology," said NSA Drug Enforcement Committee Chair Sheriff Keith Cain. "It is exciting to see this program's adoption around the country and I believe it will play a significant role in helping law enforcement deal a severe blow to the meth lab underworld."

The National Association of Drug Diversion Investigators (NADDI) is a non-profit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of prescription drug diversion.

SOURCE The National Association of Drug Diversion Investigators

SOURCE The National Association of Drug Diversion Investigators
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
3. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
4. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
6. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
7. Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month
8. K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security
9. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
10. September is National Pain Awareness Month
11. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
Post Your Comments:
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new ... Italian therapeutic drug monitoring market, including emerging tests, ...
(Date:11/25/2015)... , Nov. 25, 2015 ... addition of the "Global Brain Monitoring ... offering. --> ) has ... Brain Monitoring Devices Market 2015-2019" report ... and Markets ( ) has announced ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... 2015 , ... The moment you stop improving is the ... the needs of advisers and clients but going above and beyond to find ... service. However, there's always room for improvement, which is why the entire Consulting ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... successful and prominent nonprofit healthcare organizations in the country. They have overseen financial ... organizations, and helped advance the healthcare industry as a whole through their advocacy ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., ... the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 ... brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive not ...
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD and Cambridge Memorial ... in the Waterloo region. Using the Ocean Platform, family physicians can now order ... electronic medical record (EMR) without the need for redundant patient entry or an ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... Jobs in ... by healthcare professionals and offered by healthcare staffing agency Aureus Medical Group . ... the month of October 2015 among those searching for healthcare jobs through the company’s ...
Breaking Medicine News(10 mins):